Chemed Corporation (NYSE: CHE) reported Q4 EPS of $6.60, $0.35 better than the analyst estimate of $6.25. Revenue for the quarter came in at $585.9 million versus the consensus estimate of $586.64 million.

GUIDANCE:

Chemed Corporation sees FY2024 EPS of $23.30-$23.70, versus the consensus of $23.01.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.